Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration with The Abrams...
Former Google DeepMind Director brings over two decades of AI research expertise and industrial leadership to Genesis’ AI platform and high-performing research teams
Genesis Therapeutics,...
Outcomes4Me Inc., the developer of the leading, direct-to-patient, AI-driven platform transforming the cancer-care experience, announced that its German affiliate Outcomes4Me Germany GmbH has acquired...
Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, and Databricks, the Data and AI company, announced...
ValGenesis, Inc., the global innovator in digital validation lifecycle management, announced the launch of ValGenesis Smart GxP™, the first AI-enabled platform purpose-built to unify...
Tevogen, provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™.
Tevogen.AI™ aims to integrate advanced machine learning and predictive modeling into Tevogen...